MarketInOut Stock Screener Log In | Sign Up

Emcure Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:53
Emcure Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization335,475 mln
Float35.24 mln
Earnings Date11/03/2026

EPS

53.35
Exceptional

P / E

35.09
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.32
Borderline

1-Year Forecast

2,229.38
Attractive

Relative Strength

77 / 100
Strongly outperforming

Business Description

Founded in Pune, India in 1981, Emcure Pharmaceuticals develops and sells medicines across a wide range of health conditions, from heart disease and diabetes to cancer and HIV, serving patients in markets around the world. The company markets its treatments under several well-known brand names and has recently partnered with Novo Nordisk India to bring a weight-loss injection called Poviztra to patients.

Key Fundamentals

EPS53.35
P/E35.09
ROE21.46
RPS511
ROIC15.18
ROA11.02
Interest Cover9.89
EBITDA, mln19,635
EV / EBITDA19.65
EV / EBIT25.08
Revenue, mln96,834
EV / Revenue3.98

Quote Details

Last 1,872.00
Change 89.6 (5.03%)
Open 1,815.00
Volume 7,415
Turnover 13,880,880
Average Volume 8,847.9

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio1.43
Price / Book7.40
Price / Tangible Book9.50
Price / Free Cash Flow75.13
Debt / Equity0.31
Price / Sales3.81
PEG Ratio1.94

Financial Strength

Altman Z-Score6.89
Piotroski F-Score 5 / 9
Beneish M-Score-2.32
Price to Intrinsic Value4.09
Price to Lynch Fair Value2.08
Price to Graham Number3.99
1-Year Target Price2,229.38
Shiller PE Ratio43.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.05% 94 / 100   
1 Month -4.44% 63 / 100   
2 Months 0.96% 71 / 100   
6 Months 14% 77 / 100   
1 Year 39.99% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog